Nanobodies as potential tools for microbiological testing of live biotherapeutic products.

Autor: Dorosky RJ; Office of Vaccines Research and Review, Division of Bacterial, Parasitic and Allergenic Products, Center for Biologics Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD, USA. Robert.Dorosky@fda.hhs.gov., Schreier JE; Department of Marine Sciences, University of Georgia, Athens, GA, USA., Lola SL; Office of Vaccines Research and Review, Division of Bacterial, Parasitic and Allergenic Products, Center for Biologics Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD, USA., Sava RL; Office of Vaccines Research and Review, Division of Bacterial, Parasitic and Allergenic Products, Center for Biologics Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD, USA., Coryell MP; Office of Vaccines Research and Review, Division of Bacterial, Parasitic and Allergenic Products, Center for Biologics Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD, USA., Akue A; Office of Vaccines Research and Review, Division of Bacterial, Parasitic and Allergenic Products, Center for Biologics Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD, USA., KuKuruga M; Office of Vaccines Research and Review, Division of Bacterial, Parasitic and Allergenic Products, Center for Biologics Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD, USA., Carlson PE Jr; Office of Vaccines Research and Review, Division of Bacterial, Parasitic and Allergenic Products, Center for Biologics Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD, USA., Dreher-Lesnick SM; Office of Vaccines Research and Review, Division of Bacterial, Parasitic and Allergenic Products, Center for Biologics Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD, USA., Stibitz S; Office of Vaccines Research and Review, Division of Bacterial, Parasitic and Allergenic Products, Center for Biologics Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD, USA.

Publikováno v: AMB Express [AMB Express] 2024 Jan 20; Vol. 14 (1), pp. 9. Date of Electronic Publication: 2024 Jan 20.

Feasibility of engineered Bacillus subtilis for use as a microbiome‐based topical drug delivery platform.

Autor: Montgomery, Veronica A.¹ (AUTHOR), Wood‐Yang, Amy J.² (AUTHOR), Styczynski, Mark P.² (AUTHOR) mark.styczynski@chbe.gatech.edu, Prausnitz, Mark R.^1,2 (AUTHOR) prausnitz@gatech.edu

Publikováno v: Bioengineering & Translational Medicine. Jul2024, Vol. 9 Issue 4, p1-12. 12p.

Profiling of endogenous metabolites and changes in intestinal microbiota distribution after GEN-001 (Lactococcus lactis) administration.

Autor: Min-Gul Kim^1,2,3, Suin Kim⁴, Ji-Young Jeon¹, Seol Ju Moon^1,2, Yong-Geun Kwak^1,3, Joo Young Na⁵, SeungHwan Lee⁵, Kyung-Mi Park⁶, Hyo-Jin Kim⁶, Sang-Min Lee⁴, Seo-Yeon Choi⁴, Kwang-Hee Shin⁴ kshin@knu.ac.kr

Publikováno v: Korean Journal of Physiology & Pharmacology. Mar2024, Vol. 28 Issue 2, p153-164. 12p.

Key factors for the survival of Lactiplantibacillus plantarum IDCC 3501 in manufacturing and storage.

Autor: Kim, Young-Hoo^1,2 (AUTHOR), Choi, Yong-Keun³ (AUTHOR), Kim, Min-Goo¹ (AUTHOR), Seo, Han Sol¹ (AUTHOR), Park, Saerom³ (AUTHOR), Lee, Sang Hyun² (AUTHOR) sanghlee@konkuk.ac.kr

Publikováno v: Applied Microbiology & Biotechnology. 2024, Vol. 108 Issue 1, p1-11. 11p.

Development of Phage Lysin LysA2 for Use in Improved Purity Assays for Live Biotherapeutic Products.

Autor: Dreher-Lesnick SM; Office of Vaccines Research and Review, Division of Bacterial, Parasitic and Allergenic Products, Center for Biologics Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD 20993, USA. Sheila.Dreher-Lesnick@fda.hhs.gov., Schreier JE; Office of Vaccines Research and Review, Division of Bacterial, Parasitic and Allergenic Products, Center for Biologics Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD 20993, USA. Jeremy.Schreier@fda.hhs.gov., Stibitz S; Office of Vaccines Research and Review, Division of Bacterial, Parasitic and Allergenic Products, Center for Biologics Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD 20993, USA. Earle.Stibitz@fda.hhs.gov.

Publikováno v: Viruses [Viruses] 2015 Dec 16; Vol. 7 (12), pp. 6675-88. Date of Electronic Publication: 2015 Dec 16.